Development Scientist I, Bioanalytical Development

Alexion Pharmaceuticals, Inc.
New Haven
Jan 25, 2018
Feb 22, 2018
Employer Type
Direct Employer
Employment Type
Full Time
Position Summary

Development scientist I will be able to plan, design, execute, and analyze all own work independently; able to complete assigned projects and self-identify projects; able to multi-task projects, assist in prioritization and allocating effort accordingly. The incumbent will be able to solve complex problems, take initiatives, identifies creative solutions, have scientific curiosity and deep understanding of relevant science. In addition, the incumbent will be able to communicate cross groups and within cross functional teams, has persuasive writing and oral communication skills. The incumbent will closely collaborate with R&D, clinical, and non-clinical colleagues to fulfill bioanalysis for clinical, non-clinical and R&D studies.

Principal Responsibilities

* Engage in development and research projects independently, perform relevant testing/assays.

* Engage in assay development and validation activities.

* Perform relevant testing/assays and documentation for clinical and non-clinical study samples under GLP regulation; make detailed observations and documentation.

* Performs development and/or research in collaboration with others independently

* Support other departments with testing and assay development as needed.

* Perform LIMS and LIMS associated activities regarding sample, reagent and data inventory and tracking when it is needed

* Investigates, creates and develops new methods and technologies for project advancement independently

* Train employees on relevant laboratory techniques, SOPs, etc. as needed.

* Maintains high level of professional expertise through familiarity with scientific literature.

* Use professional concept and company's policies and procedures to solve complex problems in creative and effective ways.

* Able to demonstrate potential for technical proficiency, scientific creativity, and collaboration with others and independent thought. Able to work on problems independently in which analysis of situation or data requires a review of identifiable factors. Excises judgment within defined procedures and practices to determine appropriate action.

* Principal bioanalytical investigator or study director for non-clinical and clinical studies.

* May participate in scientific conferences and contribute to scientific journals.

* Adhere to GLP/GCP guidelines.

* Operate all basic laboratory equipment and complex instruments.

* Maintain laboratory and laboratory equipment/instrumentation. Order laboratory supplies/equipment as needed.


* MS degree in relevant biological science field with a minimum of 8-11+ years' of experience; BS degree relevant biological field with a minimum of 11+ years' of experience.

* Good understanding of bioanalytical assay development, validation, and associated data analysis

* Working knowledge of regulatory guidance documents that pertain to the bioanalytical discipline

* Good writing and oral communication skills

* Hands-on bench experiments and data analyses

* Independently plan, design, execute and analyze all own work

* Contribute to assigned projects, and able to self-identify projects

* Able to multi-task projects, and prioritizes and allocates effort

* Can solve complex problems

* Take initiatives and identify creative solutions

* Good writing and oral communication skills

* Proficient in the use of Microsoft Word, Excel and PowerPoint


* MS or BS degree in relevant biological science field

* LI-ST1

New Haven, CT, United States

No Selection

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed and commercializes Soliris? (eculizumab), the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening ultra-rare disorders. As the global leader in complement inhibition, Alexion is strengthening and broadening its portfolio of complement inhibitors, including evaluating potential indications for eculizumab in additional severe and ultra-rare disorders. Alexion's metabolic franchise includes two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare disorders, Strensiq? (asfotase alfa) to treat patients with hypophosphatasia (HPP) and Kanuma? (sebelipase alfa) to treat patients with lysosomal acid lipase deficiency (LAL-D). In addition, Alexion is advancing the most robust rare disease pipeline in the biotech industry, with highly innovative product candidates in multiple therapeutic areas.

As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Alexion, please visit or download our App for iPhones and Blackberries.

Alexion is an Equal Opportunity /Affirmative action employer SDL2017

More searches like this